Literature DB >> 832536

Treatment of respiratory infections with fosfomycin.

A Menéndez, A Tutor, A S Sousa.   

Abstract

Evaluation was made of the clinical-bacteriological results of treatment with fosfomycin on a group of 27 patients with infectious respiratory pathology. The group is made up of patients with respiratory infections diagnosed as pneumonias, bronchopneumonias, acute bronchitis and chronic bronchopneumopathies. The doses of fosfomycin used varied between 4 and 12 g/day, administered during a period of 1 or 2 weeks. The results of the treatment expressed in clinical and bacteriological parameters have been successful in 15 and 21 cases for their bacteriological response and their clinical response respectively.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 832536     DOI: 10.1159/000222075

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  3 in total

1.  Fosfomycin-ampicillin versus gentamicin-ampicillin in the treatment of critically ill patients with pneumonia.

Authors:  L R Nissen; J Jacobsen; T J Ravn; C Wahlgreen; H Auning-Hansen
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

2.  Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database.

Authors:  Dmitri Iarikov; Ronald Wassel; John Farley; Sumathi Nambiar
Journal:  Infect Dis Ther       Date:  2015-10-05

3.  Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.

Authors:  David L MacLeod; Lynn M Barker; Jennifer L Sutherland; Suzanne C Moss; Jesse L Gurgel; Thomas F Kenney; Jane L Burns; William R Baker
Journal:  J Antimicrob Chemother       Date:  2009-08-13       Impact factor: 5.790

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.